Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 1, 2022
[ Tue, Mar 01st 2022
] - WOPRAI
Mon, February 28, 2022
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
Andrew Berens Maintained (BGNE) at Buy with Decreased Target to $300 on, Feb 28th, 2022
Andrew Berens of SVB Leerink, Maintained "BeiGene, Ltd." (BGNE) at Buy with Decreased Target from $334 to $300 on, Feb 28th, 2022.
Andrew, nor any peers, have made any analyst calls on BGNE in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30